Cristobal Alhambra, Wilmington US
Cristobal Alhambra, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20080200500 | Quinoline Derivatives as Nk3 Antagonists - Compounds of Formula I | 08-21-2008 |
20080200504 | Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators - Compounds of Formula (I) wherein R | 08-21-2008 |
20080214605 | Alkyl Sulfoxide Quinolines as Nk-3 Receptor Ligands - Compounds of Formula I | 09-04-2008 |
20080234269 | N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands - Compounds of Formula I | 09-25-2008 |
20080280949 | Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators - Compounds of Formula I wherein R | 11-13-2008 |
20080287492 | Alkylpyridyl Quinolines as Nk3 Receptor Modulators - Compounds of Formula I | 11-20-2008 |
20080293765 | Alkylsulphonamide Quinolines - Compounds of Formula I | 11-27-2008 |
20080306110 | Alkylnitrile Quinolines as Nk-3 Receptor Ligands - Compounds of Formula I | 12-11-2008 |
20090030033 | Novel Compounds 894 - The invention relates to 2-aza-bicyclo[2.2.2]octane compounds and uses thereof. Particularly the invention relates to such compounds and their uses as pharmaceuticals in treating pyshoses such as schizophrenia and other diseases, disorders, or conditions. | 01-29-2009 |
20090054445 | Amide Substituted Quinolines - Compounds of Formula I | 02-26-2009 |
20100029717 | Alkylsulphonamide Quinolines - Compounds of Formula I | 02-04-2010 |